Human Tobacco Smokers in Early Abstinence Have Higher Levels of β2* Nicotinic Acetylcholine Receptors than Nonsmokers
暂无分享,去创建一个
Suchitra Krishnan-Sarin | Peter Jatlow | Edythe D London | John P Seibyl | Joel A Dubin | Stephanie O'Malley | J. Seibyl | M. Picciotto | K. Cosgrove | J. Staley | C. V. van Dyck | R. Baldwin | E. London | J. Dubin | E. Perry | S. O'Malley | S. Krishnan-Sarin | G. Tamagnan | P. Jatlow | Julie K Staley | Kelly P Cosgrove | Erica Krantzler | Erin Frohlich | Edward Perry | Kristina Estok | Eric Brenner | Ronald M Baldwin | Gilles D Tamagnan | Marina R Picciotto | Christopher H van Dyck | E. Brenner | Erica Krantzler | E. Frohlich | Kristina M. Estok | S. O’Malley
[1] L. Kozlowski,et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.
[2] Robert B. Innis,et al. 5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors , 2000 .
[3] S. Heinemann,et al. Molecular and Cellular Aspects of Nicotine Abuse , 1996, Neuron.
[4] D. Wong,et al. In vivo specific binding of [3H]1-nicotine in the mouse brain. , 1989, Life sciences.
[5] K. Keyser,et al. Chronic Nicotine Treatment Up-regulates Human α3β2 but Not α3β4 Acetylcholine Receptors Stably Transfected in Human Embryonic Kidney Cells* , 1998, The Journal of Biological Chemistry.
[6] T. Slotkin. Nicotine and the adolescent brain: insights from an animal model. , 2002, Neurotoxicology and teratology.
[7] Theo Gasser,et al. Assessing intrarater, interrater and test–retest reliability of continuous measurements , 2002, Statistics in medicine.
[8] L. Dwoskin,et al. Contribution of CNS nicotine metabolites to the neuropharmacological effects of nicotine and tobacco smoking. , 1997, Biochemical pharmacology.
[9] J. Ramos,et al. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. , 1997, Life sciences.
[10] D. Hatsukami,et al. Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.
[11] D. Wong,et al. Synthesis of an I-123 analog of A-85380 and preliminary SPECT imaging of nicotinic receptors in baboon. , 1999, Nuclear medicine and biology.
[12] R. Tyndale,et al. Variable CYP2A6-mediated nicotine metabolism alters smoking behavior and risk. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[13] D. Perry,et al. Subtype-Selective Up-Regulation by Chronic Nicotine of High-Affinity Nicotinic Receptors in Rat Brain Demonstrated by Receptor Autoradiography , 2003, Journal of Pharmacology and Experimental Therapeutics.
[14] M. Hariharan,et al. A high-performance liquid-chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. , 1988, Clinical chemistry.
[15] J. Rose,et al. Inhalation of vapor from black pepper extract reduces smoking withdrawal symptoms. , 1994, Drug and alcohol dependence.
[16] J L Lancaster,et al. Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.
[17] H. Lester,et al. Assembly of α4β2 Nicotinic Acetylcholine Receptors Assessed with Functional Fluorescently Labeled Subunits: Effects of Localization, Trafficking, and Nicotine-Induced Upregulation in Clonal Mammalian Cells and in Cultured Midbrain Neurons , 2003, The Journal of Neuroscience.
[18] R. Tyndale,et al. Down-regulation of hepatic nicotine metabolism and a CYP2A6-like enzyme in African green monkeys after long-term nicotine administration. , 2003, Molecular pharmacology.
[19] P. Crooks,et al. Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[20] J. Staley,et al. Neurochemical Substrates of Habitual Tobacco Smoking , 2007 .
[21] A. Nordberg,et al. Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.
[22] J. Seibyl,et al. SPECT imaging with the D(4) receptor antagonist L-750,667 in nonhuman primate brain. , 2000, Nuclear medicine and biology.
[23] M. Benwell,et al. Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain , 1988, Journal of neurochemistry.
[24] D. Hatsukami,et al. Tobacco withdrawal symptoms: an experimental analysis , 2005, Psychopharmacology.
[25] G. Badger,et al. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. , 1996, Journal of applied behavior analysis.
[26] J. Seibyl,et al. Nicotinic Acetylcholine Receptors in Human Brain by the Constant Infusion Paradigm: Feasibility and Reproducibility , 2005 .
[27] S. Leonard,et al. [3H]Nicotine binding in peripheral blood cells of smokers is correlated with the number of cigarettes smoked per day , 2000, Neuropharmacology.
[28] S Wonnacott,et al. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. , 1990, Trends in pharmacological sciences.
[29] Jack L. Lancaster,et al. The Talairach Daemon a database server for talairach atlas labels , 1997 .
[30] A. C. Collins,et al. Effect of Smoking History on [ 3 H]nicotine Binding in Human Postmortem Brain 1 , 2022 .
[31] E. London,et al. Radiosynthesis and preliminary evaluation of 5-[123/125I]iodo-3-(2(S)-azetidinylmethoxy)pyridine: a radioligand for nicotinic acetylcholine receptors. , 1999, Nuclear medicine and biology.
[32] P. Whiting,et al. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. , 1994, Molecular pharmacology.
[33] S. Heinemann,et al. Exocytic Trafficking Is Required for Nicotine-induced Up-regulation of α4β2 Nicotinic Acetylcholine Receptors* , 2005, Journal of Biological Chemistry.
[34] J. Changeux,et al. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.
[35] C. Rand,et al. Contingent payment procedures for smoking reduction and cessation. , 1986, Journal of applied behavior analysis.
[36] J. Changeux,et al. Nicotine Upregulates Its Own Receptors through Enhanced Intracellular Maturation , 2005, Neuron.
[37] C. Stockmeier,et al. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. , 1999, The Journal of pharmacology and experimental therapeutics.
[38] J. Seibyl,et al. Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates. , 2001, Nuclear medicine and biology.
[39] J. Changeux,et al. An Extracellular Protein Microdomain Controls Up-regulation of Neuronal Nicotinic Acetylcholine Receptors by Nicotine* , 2004, Journal of Biological Chemistry.
[40] R. D. Schwartz,et al. Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. , 1983, Science.
[41] P. Vainio,et al. Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes. , 2001, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[42] Prospective study of risk factors for the initiation of cigarette smoking. , 1997, Journal of consulting and clinical psychology.
[43] A. C. Collins,et al. Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. , 1983, The Journal of pharmacology and experimental therapeutics.
[44] R. Dannals,et al. 5-[I-125/123]lodo-3(2(S)-azetidinylmethoxy)pyridine, a radioiodinated analog of A-85380 for in vivo studies of central nicotinic acetylcholine receptors. , 1998, Life sciences.
[45] N. Millar,et al. Changes in Conformation and Subcellular Distribution of α4β2 Nicotinic Acetylcholine Receptors Revealed by Chronic Nicotine Treatment and Expression of Subunit Chimeras , 2002, The Journal of Neuroscience.
[46] D. Bertrand,et al. Chronic Exposure to Nicotine Upregulates the Human α4β2 Nicotinic Acetylcholine Receptor Function , 2001, The Journal of Neuroscience.
[47] J. Lindstrom,et al. First and second transmembrane segments of α3, α4, β2, and β4 nicotinic acetylcholine receptor subunits influence the efficacy and potency of nicotine , 2002 .
[48] B. Grant,et al. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2004, Archives of general psychiatry.
[49] A. C. Collins,et al. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] A. C. Collins,et al. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. , 1985, The Journal of pharmacology and experimental therapeutics.
[51] R. Friedland,et al. PET quantification of specific binding of carbon-11-nicotine in human brain. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[52] I G Zubal,et al. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[53] S. Tiffany,et al. The development and initial validation of a questionnaire on smoking urges. , 1991, British journal of addiction.
[54] M. Stitzer,et al. Contingent reinforcement for reduced breath carbon monoxide levels: target-specific effects on cigarette smoking. , 1985, Addictive behaviors.
[55] A. Nordberg,et al. Regulation of α4β2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents , 1995 .